XML 16 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Consolidated Statements of Cash Flows (USD $)
 3 Months Ended 150 Months Ended
Mar. 31, 2014
Mar. 31, 2013
Mar. 31, 2014
Cash flows from operating activities:      
Loss for the period $ (736,919) $ (1,343,595) $ (25,823,598)
Adjustments to reconcile loss for the period to net cash used in operating activities:      
Depreciation 8,096 7,027 199,813
Increase in liability for employee rights upon retirement    6,327 196,506
Stock-based compensation 14,701 6,151 1,630,745
Stock-based interest compensation to convertible notes holders       1,214,943
Issuance costs allocated to warrants with down-round protection    611,060 390,928
Change in the fair value of warrants issued with down-round protection (145,870)    6,069,480
Linkage difference on principal of loans from stockholders (4,717) (3,186) 196,563
Interest on convertible notes       78,192
Gain on sale of property and equipment       (912)
Gain from trading marketable securities       (12,920)
Changes in assets and liabilities:      
Decrease (increase) in other current assets 4,126 11,687 (70,526)
Increase in accounts payable 85,925 17,848 130,658
Increase in other current liabilities 86,389 41,304 320,032
Net cash used in operating activities (688,269) (645,377) (15,480,096)
Cash flows from investment activities:      
Increase in funds in respect of employee rights upon retirement       (149,221)
Purchase of property and equipment (8,854) (786) (293,226)
Proceeds from sale of property and equipment       4,791
Investment in marketable securities       (388,732)
Proceeds from sale of marketable securities       406,995
Short-term loan granted to related party, net of repayments       (14,252)
Net cash used in investment activities (8,854) (786) (433,645)
Cash flows from financing activities      
Credit from banking institutions (repayment) 23,793 (37,815) 15,122
Proceeds from issuance of convertible notes       1,144,000
Repayment of convertible notes       (527,396)
Proceeds from issuance of Common Stock, net of issuance expenses       11,323,559
Dividend to Preferred Stockholders (92,674)    (380,922)
Proceeds allocated to convertible Preferred Stock, net of issuance expenses    3,343,253 3,960,958
Proceeds allocated to warrants with "down-round" protection, net of issuance expenses    2,093,745 1,421,983
Proceeds from stockholders loans       347,742
Net cash provided by (used in) financing activities (68,881) 5,399,183 17,305,046
Effect of exchange rate changes on cash and cash equivalents (2,786) 28,909 225,816
Increase (decrease) in cash and cash equivalents (768,790) 4,781,929 1,617,121
Cash and cash equivalents at beginning of the period 2,385,911 543,411   
Cash and cash equivalents at end of the period $ 1,617,121 $ 5,325,340 $ 1,617,121